Synthetic Biology Market Overview
The Synthetic Biology Market is expanding rapidly as advances in genetic engineering, genome editing, DNA synthesis, and bioinformatics create new applications across healthcare, agriculture, industrial biotechnology, environmental management, and food production. Growing investment in biotechnology research, increasing demand for sustainable solutions, rising adoption of CRISPR technologies, and supportive regulatory initiatives are supporting market growth.
According to the WiseGuyReports report published in December 2025, the global Synthetic Biology Market was valued at USD 12.5 Billion in 2024 and is projected to grow from USD 14.0 Billion in 2025 to USD 45.0 Billion by 2035, registering a CAGR of 12.3% during 2025–2035. North America led the market with a valuation of USD 6.0 Billion in 2024 and is projected to reach approximately USD 20.5 Billion by 2035. Healthcare was valued at USD 4.5 Billion in 2024, while Agriculture is projected to reach USD 9.0 Billion by 2035.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/sample-request?id=653046
Key players driving innovation and competitiveness in the Synthetic Biology Market include:
Genomatica
JBEI
Illumina
Zymo Genomics
Ginkgo Bioworks
Novozymes
Corteva Agriscience
Codexis
E. I. du Pont de Nemours and Company
Bristol Myers Squibb
Regeneron Pharmaceuticals
Amyris
Archer Daniels Midland Company
BASF
Synthetic Genomics
The market is being shaped by increasing demand for sustainable solutions across healthcare, agriculture, industrial manufacturing, and energy. Advances in CRISPR and genome-editing technologies are enabling more precise biological modifications, while increased research funding and collaboration between academic institutions and industry are accelerating commercialization. Synthetic biology is also creating opportunities for biofuels, biodegradable materials, advanced therapeutics, customized microorganisms, and sustainable biomanufacturing.
The Synthetic Biology Market can be segmented by Application into Healthcare, Agriculture, Industrial Biotechnology, Environmental Management, and Synthetic Food Production. By Technology, it includes Gene Synthesis, Genome Editing, Gene Cloning, Sequencing Technologies, and Bioinformatics. By End Use, it covers Pharmaceuticals, Food & Beverages, Biofuels, and Agricultural Products. By Organism Type, it includes Bacteria, Yeast, Plants, and Animals. The market is also analyzed across North America, Europe, South America, Asia Pacific, and the Middle East and Africa.
The growing demand for sustainable and efficient biological manufacturing is creating opportunities for biotechnology companies, pharmaceutical manufacturers, agricultural businesses, food producers, research institutions, and industrial biotechnology providers. Biomanufacturing of sustainable products, gene editing for agricultural improvements, advanced therapeutics, custom synthetic organisms, renewable-energy applications, and environmental remediation represent important areas of opportunity.
Recent Developments and Market Trends:
Healthcare remains a major application of synthetic biology, with the segment valued at approximately USD 4.5 Billion in 2024 as pharmaceutical and biotechnology companies explore synthetic biology for drug development, biologics, diagnostics, and personalized medicine.
CRISPR and genome-editing technologies are transforming synthetic biology by enabling increasingly precise genetic modifications across healthcare, agriculture, and industrial applications.
Gene Synthesis and Genome Editing are becoming increasingly important technologies as researchers seek faster and more accurate ways to design and modify biological systems.
Sustainable biomanufacturing is gaining momentum as companies explore biological production methods for biofuels, biodegradable materials, chemicals, food ingredients, and other alternatives to conventional manufacturing.
Corteva Agriscience expanded its collaboration with Ginkgo Bioworks in June 2024 to develop microbial traits for crop protection and yield improvement, demonstrating growing industrial and agricultural applications of synthetic biology.
BASF extended its multi-year relationship with Genomatica in February 2025 to scale bio-based 1,4-butanediol production and explore additional chemicals, highlighting continued investment in industrial biotechnology.
Novozymes announced a major contract with ADM in March 2025 to provide enzyme solutions for fermentation-based production of bio-based ingredients, reflecting growing adoption of biological manufacturing processes.
North America remains the dominant regional market, supported by advanced biotechnology infrastructure, significant R&D investment, and the presence of major synthetic-biology companies. Europe is emphasizing sustainable applications and biotechnology research, while Asia Pacific is expanding through increasing investment in healthcare, agriculture, and biomanufacturing.
Reasons to Buy the Report:
Provides comprehensive insights into the Synthetic Biology Market dynamics, trends, opportunities, and growth potential.
Helps identify opportunities across healthcare, agriculture, industrial biotechnology, environmental management, and synthetic food production.
Offers detailed segmentation analysis across application, technology, end use, organism type, and geographic markets.
Includes competitive intelligence covering leading biotechnology, pharmaceutical, agricultural, food, and industrial companies.
Supports informed decisions using market forecasts, genetic-engineering advancements, R&D investment, sustainability initiatives, CRISPR adoption, biomanufacturing trends, and regional opportunities.
Future Outlook:
The future of the Synthetic Biology Market will be shaped by advances in genetic engineering, CRISPR and genome editing, increasing biotechnology investment, demand for sustainable manufacturing, and expanding applications across healthcare, agriculture, food, and industrial biotechnology. Healthcare should remain a major application area, while Agriculture is projected to reach USD 9.0 Billion by 2035 and Industrial Biotechnology is projected to reach USD 8.0 Billion.
Gene Synthesis, Genome Editing, Gene Cloning, Sequencing Technologies, and Bioinformatics will continue to provide the technological foundation for synthetic biology development. Pharmaceuticals should remain a major end-use sector, while Food & Beverages, Biofuels, and Agricultural Products provide additional opportunities for biological production and sustainable alternatives.
Bacteria and Yeast should remain important organism types for industrial and pharmaceutical applications, while engineered Plants and Animals will support specialized research and production opportunities. North America should retain market leadership, with its market projected to reach approximately USD 20.5 Billion by 2035, while Europe and Asia Pacific are expected to continue expanding as research funding, biotechnology infrastructure, and commercial adoption increase.
WiseGuyReports projects the global Synthetic Biology Market to reach USD 45.0 Billion by 2035 at a CAGR of 12.3%.
➤➤Explore Our Latest Related Reports:
